Scientific Advisory Board
Dr. Vladimir Shulaev
Dr. Vladimir Shulaev is actively working on cellular metabolites for the past 20 years and is currently the Professor in the Department of Biological Sciences at the University of North Texas. Fascinated towards science since his early years, he got his Masters in chemistry and genetics from Kiev State University. He got his first Ph.D. in botany from the Ukraine Academy of Sciences and earned another in plant biology from Rutgers University after moving to the United States.
His prominent focus of work is on plants where he is studying different plant- derived metabolites with potential health benefits. His research involves studying biochemical, cellular and molecular mechanisms of plant responses to biotic and abiotic stress. By deciphering their underlying biological mechanisms using a combination of mass spectrometry-based metabolomics, transcriptomics and systems biology approaches, he plans to engineer plants with enhanced environmental stress tolerance and plants that produce novel health-related metabolites.
Dr. Jonathan Bones
Jonathan received his PhD in Analytical Chemistry from Dublin City University in 2007. Jonathan then moved to NIBRT - The National Institute for Bioprocessing Research and Training, working under the mentorship of Prof. Pauline M. Rudd within her GlycoScience Laboratory. In 2010, Jonathan was appointed the John Hatsopoulos Research Scholar within the Barnett Institute of Chemical and Biological Analysis at Northeastern University, Boston, working under the mentorship of Prof. Barry L. Karger. Jonathan returned to NIBRT in 2012 and is the Principal Investigator of the NIBRT Characterization and Comparability Laboratory and an Associate Professor in the School of Chemical and Bioprocess Engineering at University College Dublin.
Dr. John E. Wiktorowicz
Dr. John Wiktorowicz has been a protein biochemist for over 35 years. He is the Professor of Biochemistry and Molecular Biology at the University of Texas Medical Branch in Galveston, Texas. Dr. Wiktorowicz is the Director of the Proteomics Section of the Biomolecular Resource Facility at UTMB, the flagship institution for the University of Texas System Proteomics Core Network for all 16 UT institutions. He serves as the Director of Innovative Technologies for the NHLBI Proteomics Center for Airway Inflammation, and Director of Discovery Proteomics for the NIAID Clinical Proteomics Center. He also holds the positions of Senior Scientist for the Sealy Center for Molecular Medicine and the Institute for Infection and Immunity. His main research interest is to develop new proteomics technologies to address the many challenges imposed by proteomics and to apply them to the outstanding issues in human disease.
He received his BS in Biology from the Illinois Institute of Technology in Chicago, Il, and Ph.D. in Human Biological Chemistry and Genetics from the University of Texas Medical Branch in Galveston TX. He completed his post-doctoral academic training in the Division of Biology at Caltech in Pasadena, CA as a Damon Runyon Fellow, followed by a research fellowship in the Department of Cellular Biology at the Scripps Research Institute in San Diego, CA.
Dr. Michael Tiemeyer
Dr. Michael Tiemeyer has been working in the field of glycobiology for the last three decades, with an emphasis on glycomics and glycoproteomics for the last 10 years. He is currently serving as a Professor of Biochemistry and Molecular Biology and as the Associate Director for Research at the Complex Carbohydrate Research Center (CCRC), University of Georgia. His current research focuses on mechanisms that regulate the expression, function, and structure of tissue-specific glycans. His works have been published in various journals of repute. He is actively involved in advancing glycomics research by developing workflows, tools, and analytic methods for basic research and for biomedical applications.
Dr. Tiemeyer received his B.A. in biology in 1982 from The Johns Hopkins University and his Ph.D. in neuroscience in 1989 from The Johns Hopkins University School of Medicine. He was a Helen Hay Whitney postdoctoral fellow in developmental neurobiology at the University of California at Berkeley. Prior to joining CCRC, Dr. Tiemeyer was on the faculty in the Department of Cell Biology at Yale University School of Medicine and directed biochemical and clinical analytics and new methods development at Glyko (now BioMarin), Inc.
